Adaptimmune Therapeutics PLC - SPONDS ADR (ADAP)

Q3 2022 13F Holders as of 9/30/2022

Type / Class
Equity / SPONDS ADR
Number of holders
60
Total Shares
114M
Shares change
-765K
Total reported value, excl. options
$122M
Value change
-$1.59M
Put/Call ratio
0
Number of buys
27
Number of sells
-27
Price
$1.08
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.